Evaluating the CORE-10 as an assessment measure of psychological distress in women 3 months after miscarriage

ISRCTN ISRCTN17424858
DOI https://doi.org/10.1186/ISRCTN17424858
IRAS number 215646
Secondary identifying numbers 2.0 (28-Mar-2024), IRAS 215646, CPMS 32263
Submission date
16/07/2024
Registration date
06/08/2024
Last edited
21/01/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
In the UK it is estimated that mental illness affects 1 in 5 women during pregnancy and after birth with a cost to society of £8.1 billion for every annual cohort of births. Miscarriage is defined as the loss of a pregnancy before viability, which in the UK includes pregnancy losses from conception until 23 weeks and 6 days gestation. Miscarriage is common with an estimated 23 million miscarriages occurring every year worldwide, translating to 44 pregnancy losses each minute.
Miscarriage can be a deeply distressing experience. The psychological impact of miscarriage can go unrecognised by healthcare professionals, family and friends. However, anxiety, depression and PTSD are all strongly associated with miscarriage. In 2020, a study of 537 women following miscarriage found that 9 months after a pregnancy loss, 6% of women met the criteria for moderate or severe depression, 17% for moderate or severe anxiety and 18% for post-traumatic stress. Identifying women at risk of psychological distress following miscarriage and the development of optimal treatment strategies have been recognised as research priorities. This study aims to evaluate the diagnosis accuracy of the CORE-10 online questionnaire in identifying women who meet the DSM-V diagnostic criteria for psychopathology.

Who can participate?
Women aged 18 years and over who have experienced an involuntary pregnancy loss (miscarriage <24 weeks, stillbirth, neonatal death, ectopic pregnancy, gestational trophoblastic disease [molar pregnancy], or recurrent miscarriage)

What does the study involve?
Work package 1: This work package will involve confirmation of any subsequent pregnancy since the miscarriage diagnosis was made, completion of the CORE-10 questionnaire and a diagnostic interview completed online via the online CORE-10 database.
Work package 2: About 40 women from WP1 will complete surveys and interviews to evaluate their perspective of the CORE-10 online questionnaire.

What are the possible benefits and risks of participating?
At the moment there is not enough evidence to say whether the CORE-10 is the best way of identifying women who have prolonged psychological distress following miscarriage.
It is not known whether participants will benefit personally from taking part in this study, but the knowledge gained will inform future practice and potentially lead to improved detection of mental health problems for women after miscarriage in the future.

Where is the study run from?
University of Birmingham (UK)

When is the study starting and how long is it expected to run for?
November 2023 to September 2025

Who is funding the study?
Tommy’s (UK)

Who is the main contact?
core-10@contacts.bham.ac.uk

Study website

Contact information

Mr Lee Priest
Public, Scientific

Tommy’s National Centre for Miscarriage Research (Birmingham)
WHO Collaborating Centre for Global Women’s Health
School of Medical Science
Metabolism and Systems Science
University of Birmingham
Birmingham
B15 2TH
United Kingdom

Phone N/A
Email l.priest.1@bham.ac.uk
Prof Arri Coomarasamy
Principal Investigator

Tommy’s National Centre for Miscarriage Research (Birmingham)
WHO Collaborating Centre for Global Women’s Health
School of Medical Science
Metabolism and Systems Science
University of Birmingham
Birmingham
B15 2TH
United Kingdom

Phone N/A
Email a.coomarasamy@bham.ac.uk
Dr Rosinder Kaur
Scientific

Birmingham Women's and Children's NHS Foundation Trust
Mindelsohn Way
Birmingham
B15 2TG
United Kingdom

Phone N/A
Email rosinder.kaur@nhs.net
Dr Emily Fox
Scientific

Birmingham Women's and Children's NHS Foundation Trust
Mindelsohn Way
Birmingham
B15 2TG
United Kingdom

Phone N/A
Email e.fox3@nhs.net
Dr Adam Devall
Scientific

Tommy’s National Centre for Miscarriage Research (Birmingham)
WHO Collaborating Centre for Global Women’s Health
School of Medical Science
Metabolism and Systems Science
University of Birmingham
Birmingham
B15 2TH
United Kingdom

Phone N/A
Email a.j.devall@bham.ac.uk

Study information

Study designObservational study
Primary study designObservational
Secondary study designDiagnosis accuracy study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEvaluating the CORE-10 as an assessment measure of psychological distress in women 3 months after miscarriage
Study acronymCORE-10
Study hypothesisThis work package aims to evaluate the diagnosis accuracy of the CORE-10 online questionnaire in identifying women who meet DSM-V diagnostic criteria for psychopathology.
Ethics approval(s)

Approved 20/02/2024, West Midlands - South Birmingham Research Ethics Committee (2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; +44 (0)207 104 8230; southbirmingham.rec@hra.nhs.uk), ref: 16/WM/0423

ConditionMiscarriage
InterventionThe Clinical Outcomes in Routine Evaluation (CORE-10) was suggested as a possible single tool to screen for psychological distress. There was an agreement amongst professionals regarding the availability and ease of use of the tool. CORE-10 is a strong tool for assessing psychological distress in women given its broad coverage of a range of constructs and familiarity with clinicians.

The CORE-10 online questionnaire is used to identify women who meet DSM-V diagnostic criteria for psychopathology. This work package will involve confirmation of any subsequent pregnancy since the miscarriage diagnosis was made, completion of the CORE-10 questionnaire and a diagnostic interview which are completed online via the online CORE-10 database (Redcap).
Intervention typeOther
Primary outcome measurePsychological distress is measured using the Clinical Outcomes in Routine Evaluation (CORE-10) online questionnaire, and completed by women 3 months following a miscarriage (work package 1). The CORE-10 questionnaire will be compared with the results of the clinical diagnostic interview (completed within 28 days from the date of the CORE-10 questionnaire).
Secondary outcome measuresThe acceptability of the CORE-10 online questionnaire will be measured by survey, clinical interview and completion of a Likert Scale (work package 2). Forty participants will be randomly selected after the completion of the diagnostic clinical interview.
Overall study start date11/11/2023
Overall study end date30/09/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants595
Participant inclusion criteria1. Female
2. Primiparous or multiparous
3. Ability to provide written informed consent to take part in the study
4. Age ≥18 years old
5. Diagnosis of miscarriage ≤16+6 weeks (singleton or multiple pregnancies) acquired from hospital records
6. Recurrent or sporadic miscarriage
Participant exclusion criteria1. Miscarriage ≥17 weeks
2. Other types of early pregnancy loss (e.g. gestational trophoblastic disease or ectopic pregnancy) acquired from hospital records
3. Termination of pregnancy
4. Prior enrolment in this study
Recruitment start date07/08/2024
Recruitment end date31/05/2025

Locations

Countries of recruitment

  • England
  • Scotland
  • United Kingdom

Study participating centres

NHS Grampian
Dugald Baird Centre
Aberdeen Maternity Hospital
Aberdeen
AB25 2ZL
United Kingdom
Ashford and St. St. Peter’s Hospitals NHS Foundation Trust
Ashford & St Peter's Hospitals NHS Foundation Trust
1st floor, Chertsey House
St Peter's Hospital
Guildford Road
Chertsey
Surrey
KT16 OPZ
United Kingdom
Birmingham Women's and Children's NHS Foundation Trust
Steelhouse Lane
West Midlands
Birmingham
B4 6NH
United Kingdom
Imperial College Healthcare NHS Trust
Praed Street
London
W2 1NY
United Kingdom
King's College Hospital NHS Foundation Trust
Denmark Hill
London
SE5 9RS
United Kingdom
University Hospitals Of Leicester NHS Trust
Kensington Building
Leicester Royal Infirmary
Leicester
LE1 5WW
United Kingdom
Shrewsbury and Telford Hospital NHS Trust
The Princess Royal Hospital
Apley Castle
Apley
Telford
TF1 6TF
United Kingdom
NHS Lothian
Waverleygate
2-4 Waterloo Place
Edinburgh
EH1 3EG
United Kingdom
Lancashire Teaching Hospitals NHS Foundation Trust
Womens Health Research Office
Ante-Natal Clinic
Royal Preston Hospital
Fulwood
Preston
PR2 9HT
United Kingdom
South Tyneside and Sunderland NHS Foundation Trust
Sunderland Royal Hospital
Kayll Rd, Sunderland
Sunderland
SR4 7TP
United Kingdom
University Hospitals Coventry & Warwickshire
Clifford Bridge Road
Coventry
CV2 2DX
United Kingdom

Sponsor information

University of Birmingham
University/education

Edgbaston
Birmingham
B15 2TT
England
United Kingdom

Phone N/A
Email researchgovernance@contacts.bham.ac.uk
Website http://www.birmingham.ac.uk/index.aspx
ROR logo "ROR" https://ror.org/03angcq70

Funders

Funder type

Charity

Tommy's
Private sector organisation / Other non-profit organizations
Location
United Kingdom

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planA manuscript will be submitted to peer reviewed publications. Through a variety of platforms, data will be shared with patients, commissioners, clinicians, third sector organisations and policy makers. A supplementary lay summary will also be provided within the report to ensure wide dissemination amongst clinicians, patients and the public. The study findings will also be presented at key international conferences. All publications will acknowledge participants and EPAUs. These dissemination strategies will ensure widespread disseminated to the NHS, wider public and researchers.
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from core-10@contacts.bham.ac.uk
The type of data that will be shared: Appropriate data-sharing requests will be considered by the trial management group and the Tommy’s Management Centre. Any data shared will be anonymous.
Data will be stored securely in a redcap database on servers at the University of Birmingham. Personal data recorded on all documents will be regarded as strictly confidential and will be handled and stored in accordance with the General Data Protection Regulation, 2018.

Editorial Notes

21/01/2025: The following changes were made to the trial record:
1. The recruitment end date was changed from 31/01/2025 to 31/05/2025.
2. The overall end date was changed from 31/05/2025 to 30/09/2025.
3. The intention to publish date was changed from 01/06/2025 to 31/12/2025.
4. The plain English summary was updated to reflect these changes.
10/09/2024: Internal review.
27/08/2024: Internal review.
16/07/2024: Study's existence confirmed by the West Midlands - South Birmingham Research Ethics Committee.